BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18597677)

  • 1. APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
    Strebel K; Khan MA
    Retrovirology; 2008 Jul; 5():55. PubMed ID: 18597677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of APOBEC3G binding to 7SL RNA.
    Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
    Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.
    Maeda K; Almofty SA; Singh SK; Eid MMA; Shimoda M; Ikeda T; Koito A; Pham P; Goodman MF; Sakaguchi N
    J Immunol; 2013 Dec; 191(12):6030-6039. PubMed ID: 24198285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
    Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
    J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions.
    Khan MA; Goila-Gaur R; Opi S; Miyagi E; Takeuchi H; Kao S; Strebel K
    Retrovirology; 2007 Jul; 4():48. PubMed ID: 17631688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.
    Apolonia L; Schulz R; Curk T; Rocha P; Swanson CM; Schaller T; Ule J; Malim MH
    PLoS Pathog; 2015 Jan; 11(1):e1004609. PubMed ID: 25590131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles.
    Tian C; Wang T; Zhang W; Yu XF
    Nucleic Acids Res; 2007; 35(21):7288-302. PubMed ID: 17959647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
    Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
    J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10.
    Liu C; Zhang X; Huang F; Yang B; Li J; Liu B; Luo H; Zhang P; Zhang H
    J Biol Chem; 2012 Aug; 287(35):29373-83. PubMed ID: 22791714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.
    Khan MA; Goila-Gaur R; Kao S; Miyagi E; Walker RC; Strebel K
    Retrovirology; 2009 Nov; 6():99. PubMed ID: 19886996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of sequence-specific RNA recognition by the antiviral factor APOBEC3G.
    Yang H; Kim K; Li S; Pacheco J; Chen XS
    Nat Commun; 2022 Dec; 13(1):7498. PubMed ID: 36470880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between HIV-1 Gag and APOBEC3G.
    Cen S; Guo F; Niu M; Saadatmand J; Deflassieux J; Kleiman L
    J Biol Chem; 2004 Aug; 279(32):33177-84. PubMed ID: 15159405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC3G incorporation into human immunodeficiency virus type 1 particles.
    Zennou V; Perez-Caballero D; Göttlinger H; Bieniasz PD
    J Virol; 2004 Nov; 78(21):12058-61. PubMed ID: 15479846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA.
    Yang B; Chen K; Zhang C; Huang S; Zhang H
    J Biol Chem; 2007 Apr; 282(16):11667-75. PubMed ID: 17272283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
    Liu B; Yu X; Luo K; Yu Y; Yu XF
    J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging.
    Wang T; Tian C; Zhang W; Sarkis PT; Yu XF
    J Mol Biol; 2008 Jan; 375(4):1098-112. PubMed ID: 18067920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particles.
    Didierlaurent L; Racine PJ; Houzet L; Chamontin C; Berkhout B; Mougel M
    Nucleic Acids Res; 2011 Nov; 39(20):8915-27. PubMed ID: 21791531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.
    Newman EN; Holmes RK; Craig HM; Klein KC; Lingappa JR; Malim MH; Sheehy AM
    Curr Biol; 2005 Jan; 15(2):166-70. PubMed ID: 15668174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.
    Polevoda B; Joseph R; Friedman AE; Bennett RP; Greiner R; De Zoysa T; Stewart RA; Smith HC
    J Biol Chem; 2017 May; 292(21):8642-8656. PubMed ID: 28381554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.
    Zhang W; Du J; Yu K; Wang T; Yong X; Yu XF
    J Virol; 2010 Dec; 84(24):12903-13. PubMed ID: 20926562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.